journal cover

Mitiglinide for type 2 diabetes treatment

Expert Opinion on Pharmacotherapy

Sep 3, 2013

Haley M Phillippe, Kurt A Wargo

Download from

Publisher
PubMed

Abstract

Mitiglinide , a rapid-acting insulin secretion-stimulating agent, is approved in Japan for the treatment of type 2 diabetes (T2DM). Rapid-acting insulin secretion-stimulating agents, also known as meglitinides, are not recommended as monotherapy, however, may be added to metformin thera...read more

Mentioned in this Paper

Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Nateglinide
Metformin
Meglitinide
Chronic Kidney Insufficiency
Adverse Effects
Isoindoles
Metabolic Pathway
S21403
16
Paper Details
References
  • References19
  • Citations8
12
  • References19
  • Citations8
1

Feeds With Similar Papers

Kidney Disease & Type 2 Diabetes

High blood glucose levels can damage the glomerulus and lead to thickening of the glomerular basement membrane, over time resulting in kidney deterioration and failure. At present, there is no cure. Here is the latest research on kidney diseases in individuals with type 2 diabetes.

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

© 2020 Meta ULC. All rights reserved

Mitiglinide for type 2 diabetes treatment

Expert Opinion on Pharmacotherapy

Sep 3, 2013

Haley M Phillippe, Kurt A Wargo

PMID: 23992284

DOI: 10.1517/14656566.2013.834048

Abstract

Mitiglinide , a rapid-acting insulin secretion-stimulating agent, is approved in Japan for the treatment of type 2 diabetes (T2DM). Rapid-acting insulin secretion-stimulating agents, also known as meglitinides, are not recommended as monotherapy, however, may be added to metformin thera...read more

Mentioned in this Paper

Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Nateglinide
Metformin
Meglitinide
Chronic Kidney Insufficiency
Adverse Effects
Isoindoles
Metabolic Pathway
S21403
16

Feeds With Similar Papers

Kidney Disease & Type 2 Diabetes

High blood glucose levels can damage the glomerulus and lead to thickening of the glomerular basement membrane, over time resulting in kidney deterioration and failure. At present, there is no cure. Here is the latest research on kidney diseases in individuals with type 2 diabetes.

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

Related Papers

Paper Details
References
  • References19
  • Citations8
12
  • References19
  • Citations8
1

Download from

Publisher
PubMed
/papers/mitiglinide-for-type-2-diabetes/23992284